Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 15151-15200 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03777215
Angiotensin-(1-7) and Energy Expenditure in Human Obesity
EARLY_PHASE1Active, not recruiting
30 participants
Started: Sep 26, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04033445
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
PHASE2/PHASE3Active, not recruiting
1,064 participants
Started: Sep 26, 2019 · Completed: Oct 27, 2027
1 condition1 sponsor391 locations
NCT06727357
"Next Generation Sequencing-based Oncochip for Therapeutic Decision in Metastatic Breast Cancer. Study SHARP"
PHASE2Active, not recruiting
38 participants
Started: Sep 26, 2019 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT03900884
Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer
PHASE1Active, not recruiting
17 participants
Started: Sep 25, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT03933904
Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease
PHASE2Active, not recruiting
7 participants
Started: Sep 25, 2019 · Completed: Jun 30, 2026
2 conditions1 sponsor4 locations
NCT04069299
Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract
N/AActive, not recruiting
30 participants
Started: Sep 25, 2019 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT04018859
Platelet-rich Plasma for Eyebrows
PHASE2Active, not recruiting
11 participants
Started: Sep 25, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04136054
Better Sleep in Psychiatric Care - Depression, Anxiety and PTSD
NAActive, not recruiting
130 participants
Started: Sep 25, 2019 · Completed: Jun 30, 2025
3 conditions2 sponsors1 location
NCT03803774
Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma
PHASE1Active, not recruiting
13 participants
Started: Sep 25, 2019 · Completed: Jul 9, 2026
3 conditions1 sponsor33 locations
NCT04060927
Pilot Study of SGRT Alone vs. SGRT With Fiducials for Breath Hold SBRT tx of the Lung
NAActive, not recruiting
45 participants
Started: Sep 25, 2019 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT03915184
Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)
PHASE1/PHASE2Active, not recruiting
105 participants
Started: Sep 25, 2019 · Completed: Dec 31, 2034
1 condition1 sponsor13 locations
NCT03999424
Autologous Human Schwann Cells in Peripheral Nerve Repair
PHASE1Active, not recruiting
5 participants
Started: Sep 24, 2019 · Completed: Sep 1, 2026
1 condition2 sponsors1 location
NCT04090736
Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy
PHASE3Active, not recruiting
302 participants
Started: Sep 24, 2019 · Completed: Jun 30, 2025
1 condition3 sponsors62 locations
NCT04106414
Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment
PHASE2Active, not recruiting
24 participants
Started: Sep 24, 2019 · Completed: Sep 30, 2026
2 conditions2 sponsors7 locations
NCT05726617
Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health Disorders
NAActive, not recruiting
32 participants
Started: Sep 24, 2019 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT04611503
PDE6A Gene Therapy for Retinitis Pigmentosa
PHASE1/PHASE2Active, not recruiting
9 participants
Started: Sep 24, 2019 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT04093596
Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)
PHASE1Active, not recruiting
132 participants
Started: Sep 23, 2019 · Completed: Sep 30, 2027
1 condition1 sponsor11 locations
NCT03917082
Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer
PHASE2Active, not recruiting
290 participants
Started: Sep 23, 2019 · Completed: May 1, 2029
2 conditions3 sponsors1 location
NCT03657576
Trial of C134 in Patients With Recurrent GBM
PHASE1Active, not recruiting
19 participants
Started: Sep 23, 2019 · Completed: Sep 30, 2026
3 conditions3 sponsors1 location
NCT03130244
Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes
NAActive, not recruiting
15 participants
Started: Sep 23, 2019 · Completed: Dec 30, 2025
2 conditions1 sponsor1 location
NCT04040088
An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors
EARLY_PHASE1Active, not recruiting
20 participants
Started: Sep 23, 2019 · Completed: Jul 31, 2026
3 conditions1 sponsor1 location
NCT04704609
Imaging Quantification of Inflammation (IQI)
N/AActive, not recruiting
50 participants
Started: Sep 22, 2019 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT03781063
Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
PHASE2Active, not recruiting
100 participants
Started: Sep 20, 2019 · Completed: Dec 31, 2024
1 condition2 sponsors51 locations
NCT04095364
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE3Active, not recruiting
450 participants
Started: Sep 20, 2019 · Completed: Feb 1, 2028
12 conditions2 sponsors911 locations
NCT03950076
EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
PHASE4Active, not recruiting
948 participants
Started: Sep 20, 2019 · Completed: Oct 31, 2026
2 conditions1 sponsor152 locations
NCT04067713
Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer
N/AActive, not recruiting
192 participants
Started: Sep 20, 2019 · Completed: Oct 1, 2030
1 condition2 sponsors16 locations
NCT04083339
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
PHASE3Active, not recruiting
675 participants
Started: Sep 20, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor79 locations
NCT03993925
Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong Kong
N/AActive, not recruiting
800 participants
Started: Sep 20, 2019 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT03940703
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
PHASE2Active, not recruiting
140 participants
Started: Sep 19, 2019 · Completed: Oct 31, 2025
1 condition2 sponsors179 locations
NCT04023370
Evaluation of the Efficacy and Safety of the Application of BeGraft Peripheral Stent Graft System
NAActive, not recruiting
182 participants
Started: Sep 19, 2019 · Completed: Aug 31, 2025
1 condition2 sponsors12 locations
NCT04029714
Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative Treatment
NAActive, not recruiting
195 participants
Started: Sep 19, 2019 · Completed: Dec 31, 2033
1 condition3 sponsors5 locations
NCT04961710
Extension Study of Hetrombopag in Severe Aplastic Anemia
PHASE3Active, not recruiting
157 participants
Started: Sep 19, 2019 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04169191
Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia
PHASE1Active, not recruiting
20 participants
Started: Sep 19, 2019 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04146818
Study of the Effects of Adapted Tango and Multidimensional Intervention in pREvention of Dementia in agiNG (STRENGTH)
NAActive, not recruiting
300 participants
Started: Sep 19, 2019 · Completed: Jun 29, 2024
1 condition2 sponsors1 location
NCT05586750
Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy
PHASE4Active, not recruiting
341 participants
Started: Sep 19, 2019 · Completed: Sep 30, 2026
7 conditions2 sponsors2 locations
NCT04024163
Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease
PHASE3Active, not recruiting
178 participants
Started: Sep 19, 2019 · Completed: Mar 30, 2028
1 condition2 sponsors9 locations
NCT02595879
Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer
PHASE1Active, not recruiting
21 participants
Started: Sep 18, 2019 · Completed: Apr 29, 2026
13 conditions1 sponsor17 locations
NCT03305250
Arrhythmia Burden, Risk of Sudden Cardiac Death and Stroke in Patients With Fabry Disease
NAActive, not recruiting
169 participants
Started: Sep 18, 2019 · Completed: Jul 31, 2027
1 condition7 sponsors7 locations
NCT04094961
Ixazomib + Pomalidomide + Dexamethasone In MM
PHASE1/PHASE2Active, not recruiting
52 participants
Started: Sep 18, 2019 · Completed: Jan 1, 2027
2 conditions2 sponsors1 location
NCT03952351
Troponin in Acute Chest Pain to Risk Stratify and Guide EffecTive Use of Computed Tomography Coronary Angiography
NAActive, not recruiting
3,170 participants
Started: Sep 18, 2019 · Completed: Feb 28, 2026
1 condition5 sponsors9 locations
NCT04098393
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
PHASE1Active, not recruiting
39 participants
Started: Sep 18, 2019 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT07024914
Effect of Oxygen Supplementation on Cerebral Oxygenation, Symptoms and Performance During STST in COPD Patients
NAActive, not recruiting
25 participants
Started: Sep 18, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04186013
Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer
PHASE2Active, not recruiting
39 participants
Started: Sep 18, 2019 · Completed: May 31, 2027
1 condition3 sponsors10 locations
NCT04281771
Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI
NAActive, not recruiting
92 participants
Started: Sep 17, 2019 · Completed: Oct 28, 2026
6 conditions1 sponsor1 location
NCT04083599
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
PHASE1/PHASE2Active, not recruiting
350 participants
Started: Sep 17, 2019 · Completed: Nov 30, 2026
6 conditions2 sponsors76 locations
NCT04011722
Portico Next Generation Approval Study
NAActive, not recruiting
333 participants
Started: Sep 17, 2019 · Completed: Dec 31, 2027
1 condition1 sponsor28 locations
NCT04008706
Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients
PHASE3Active, not recruiting
552 participants
Started: Sep 17, 2019 · Completed: Oct 31, 2025
1 condition2 sponsors108 locations
NCT04002141
Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis
PHASE2Active, not recruiting
65 participants
Started: Sep 17, 2019 · Completed: Jan 1, 2025
2 conditions1 sponsor1 location
NCT04095234
Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT)
PHASE2Active, not recruiting
300 participants
Started: Sep 17, 2019 · Completed: Sep 30, 2026
1 condition1 sponsor8 locations
NCT04108897
Analysis of the Microbiome in Rosacea
EARLY_PHASE1Active, not recruiting
150 participants
Started: Sep 17, 2019 · Completed: Sep 30, 2027
1 condition1 sponsor1 location